Madrid, Spain

Fernando CilleroGrafulla

This inventor holds 1 USPTO granted patent. Top assignee: Alter, S.a.. Active years: 1977.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Fernando CilleroGrafulla

Introduction

Fernando CilleroGrafulla is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of chemistry, particularly in the area of purifying chemical compounds. His work has implications for various applications, including those related to health and wellness.

Latest Patents

CilleroGrafulla holds a patent for a process aimed at purifying the mixed ester, ethylene glycol 1-/2-(p-chlorophenoxy)-2-methylpropionate/-2-nicotinate. This innovative process involves passing the compound in oily form through a layer of Super-Cel and charcoal, followed by crystallization from a mixture of benzene and petroleum ether. The resulting compound exhibits hypolipidemic properties, which can be beneficial in medical applications.

Career Highlights

CilleroGrafulla is associated with Alter, S.A., where he continues to advance his research and development efforts. His work at the company reflects his commitment to innovation and the practical application of his inventions in the industry.

Collaborations

One of his notable collaborators is Carlos Sunkel Letelier. Together, they contribute to the advancement of their field through shared expertise and innovative ideas.

Conclusion

Fernando CilleroGrafulla's contributions to the field of chemistry, particularly through his patent for purifying chemical compounds, highlight his role as an influential inventor. His work not only showcases his innovative spirit but also has the potential to impact various applications in health and wellness.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…